| scholarly article | Q13442814 |
| P2093 | author name string | H. M. Wisniewski | |
| P. B. Kozlowski | |||
| P2860 | cites work | Experimental Pathology | Q27710845 |
| Neurofibrillary pathology: Current status and research perspectives | Q30877965 | ||
| A specific immunofluorescence technique for the demonstration of vasogenic brain edema in paraffin embedded material | Q40987040 | ||
| An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations | Q41601236 | ||
| Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques | Q41982458 | ||
| Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique | Q48446165 | ||
| Observations on the brains of demented old people | Q48896308 | ||
| Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent | Q49145357 | ||
| The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes | Q70136807 | ||
| Ultrastructural cytochemical studies of cerebral microvasculature in scrapie infected mice | Q72465739 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| blood–brain barrier | Q221694 | ||
| history and philosophy of science | Q5774812 | ||
| senile dementia | Q11610626 | ||
| Blood-Brain Barrier | Q70663706 | ||
| P304 | page(s) | 119-129 | |
| P577 | publication date | 1982-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Evidence for Blood-Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT) | |
| P478 | volume | 396 |
| Q55234157 | A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease. |
| Q48305130 | A monoclonal antibody to amyloid in the brains of patients with Alzheimer's disease |
| Q36888341 | A phenotypic change but not proliferation underlies glial responses in Alzheimer disease |
| Q28271616 | Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier |
| Q42165184 | Alzheimer's disease through the eye of a mouse. Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize |
| Q48679838 | Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes |
| Q52062315 | Angioarchitectonics of the cerebral cortex and the blood-brain barrier in Alzheimer's disease. |
| Q41329359 | Antibodies in serum of patients with Alzheimer's disease cause immunolysis of cholinergic nerve terminals from the rat cerebral cortex. |
| Q36906744 | Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils |
| Q48256017 | Biochemical assay for amyloid beta deposits to distinguish Alzheimer's disease from other dementias |
| Q41437782 | Blood brain barrier in ageing and Alzheimer's disease |
| Q48824019 | Blood-Brain Barrier Abnormalities in Alzheimer's Diseasea |
| Q41660607 | Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease |
| Q37216153 | Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. |
| Q45180931 | Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study |
| Q73406136 | Bovine serum albumin and lysophosphatidic acid stimulate calcium mobilization and reversal of cAMP-induced stellation in rat spinal cord astrocytes |
| Q38920531 | Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease. |
| Q45828263 | Changes in the distribution of anionic sites in brain micro-blood vessels with and without amyloid deposits in scrapie-infected mice |
| Q35738024 | Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease |
| Q53308132 | Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. |
| Q39645819 | Effect of aging on the blood-brain barrier |
| Q43580955 | Effects of chronic metrifonate treatment on cholinergic enzymes and the blood-brain barrier |
| Q41409747 | Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease |
| Q44529786 | Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography |
| Q59136184 | Functional alterations of myeloid cells during the course of Alzheimer's disease |
| Q34319529 | Glutamate: its role in learning, memory, and the aging brain |
| Q37034318 | Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide |
| Q35612951 | Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain |
| Q37825924 | Immune maintenance of self in morphostasis of distinct tissues, tumour growth and regenerative medicine. |
| Q28276677 | Immunohistochemical localization of intracellular plasma proteins in the human central nervous system |
| Q48224335 | Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease |
| Q41152803 | Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. |
| Q34788958 | Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models |
| Q53304073 | Lack of evidence for dysfunction of the blood-brain barrier in Alzheimer's disease: an immunohistochemical study. |
| Q92608299 | Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease |
| Q47650466 | MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies |
| Q39706123 | Metabolism and nervous system disease: a challenge for our times. Part I. |
| Q36308029 | Molecular and cellular biology of Alzheimer amyloid |
| Q39577899 | Molecular and genetic investigations on Alzheimer brain amyloid |
| Q38810704 | Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model |
| Q42513553 | Optic nerve microvessels: a partial molecular definition of cell surface anionic sites |
| Q48684196 | Penetration and internalization of plasma proteins in the human spinal cord |
| Q33865528 | Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis |
| Q30419530 | Possible factors in the etiology of Alzheimer's disease |
| Q72569751 | Prognosis in inferior myocardial infarct |
| Q34315031 | Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease |
| Q42774166 | Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases |
| Q24299918 | Reciprocal Modulation of Astrocyte Stellation by Thrombin and Protease Nexin-1 |
| Q35155267 | Serum amyloid p and related molecules associated with the acute-phase response in alzheimer's disease |
| Q44647737 | Serum creatine kinase BB isoenzyme levels in an epidemiological study of dementia and cognitive impairment |
| Q41547194 | Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat |
| Q36251986 | The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity |
| Q39554675 | The cortical dementias |
| Q39765984 | The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease |
| Q38677444 | The pathogenesis and progression of the pathological changes of Alzheimer's disease |
| Q48103149 | The postmortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA |
| Q41695322 | The relationship between blood pressure and dementia: a review |
| Q73881044 | The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system |
| Q42504990 | Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). |
| Q48812765 | Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques |
| Q69102316 | Ultrastructural observations of spinal cord lesions and blood-brain barrier changes in scrapie-infected mice |
| Q35564095 | Utilization of lectin-histochemistry in forensic neuropathology: lectin staining provides useful information for postmortem diagnosis in forensic neuropathology |
| Q64986754 | Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It? |
| Q34502082 | Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research |
| Q53199471 | X-ray microprobe analysis of corpora amylacea. |
Search more.